Robert Edward Hogan (R Edward Hogan, Robert E Hogan, Edward R Hogan)

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 21

Top Topics

Magnetic Resonance

Randomized Controlled Trial

Temporal Lobe Epilepsy

Top Venues

Epilepsy currents

Epileptic disorders : international epilepsy journal with videotape

This page only lists publications with an associated author ORCID identifier.

Publications

James W Wheless, Robert Edward Hogan, Charles S Davis, Enrique Carrazana, Adrian L Rabinowicz
Safety and effectiveness of diazepam nasal spray in male and female patients: Post hoc analysis of data from a phase 3 safety study. Epilepsia open 9 (2) (2024)
James W Wheless, Robert Edward Hogan, Charles S Davis, Enrique Carrazana, Adrian L Rabinowicz
Safety and effectiveness of diazepam nasal spray in male and female patients: Post hoc analysis of data from a phase 3 safety study. Epilepsia open 9 (2) (2024)
James W Wheless, Robert Edward Hogan, Charles S Davis, Enrique Carrazana, Adrian L Rabinowicz
Safety and effectiveness of diazepam nasal spray in male and female patients: Post hoc analysis of data from a phase 3 safety study. Epilepsia open (2024)
Chetan Sateesh Nayak, Tina Kiguradze, Fábio Augusto Nascimento, Robert Edward Hogan
Epilepsy with eyelid myoclonia. Epileptic disorders : international epilepsy journal with videotape (2023)
Chetan Sateesh Nayak, Mohammad Mehdi Kafashan, Fábio Augusto Nascimento, Nuri B Farber, Ben Julian A Palanca, Robert Edward Hogan
Movements and central positive complexes (CPCs) during an ECT-induced seizure: a video-EEG case. Epileptic disorders : international epilepsy journal with videotape (2023)
Mickael R Sperling, James W Wheless, Robert Edward Hogan, Dennis Dlugos, Gregory D Cascino, Kore Liow, Adrian L Rabinowicz, Enrique Carrazana, null null
Use of second doses of Valtoco® (diazepam nasal spray) across 24 hours after the initial dose for out-of-hospital seizure clusters: Results from a phase 3, open-label, repeat-dose safety study. Epilepsia 63 (4) (2022)
Patrick H Luckett, Luigi Maccotta, John J Lee, Ki Yun Park, Nico U F Dosenbach, Beau M Ances, Robert Edward Hogan, Joshua S Shimony, Eric C Leuthardt
Deep learning resting state functional magnetic resonance imaging lateralization of temporal lobe epilepsy. Epilepsia 63 (6) (2022)
Gregory D Cascino, Daniel Tarquinio, James W Wheless, Robert Edward Hogan, Mickael R Sperling, Jay Desai, Blanca Vazquez, Emil Samara, Sunita N Misra, Enrique Carrazana, Adrian L Rabinowicz, null null
Lack of clinically relevant differences in safety and pharmacokinetics after second-dose administration of intranasal diazepam within 4 h for acute treatment of seizure clusters: A population analysis. Epilepsia 63 (7) (2022)
Eric B Segal, Daniel Tarquinio, Ian Miller, James W Wheless, Dennis Dlugos, Victor Biton, Gregory D Cascino, Jay Desai, Robert Edward Hogan, Kore Liow, Mickael R Sperling, Blanca Vazquez, David F Cook, Adrian L Rabinowicz, Enrique Carrazana, null null
Evaluation of diazepam nasal spray in patients with epilepsy concomitantly using maintenance benzodiazepines: An interim subgroup analysis from a phase 3, long-term, open-label safety study. Epilepsia 62 (6) (2021)
Barbara C Jobst, Kelly R Conner, Douglas Coulter, Itzhak Fried, Shanna Guilfoyle, Lawrence J Hirsch, Robert Edward Hogan, Jennifer L Hopp, Dean Naritoku, Madona Plueger, Catherine A Schevon, Gigi Smith, Ignacio Valencia, William Davis Gaillard
Highlights From AES2020, a Virtual American Epilepsy Society Experience. Epilepsy currents (2021)
James W Wheless, Ian Miller, Robert Edward Hogan, Dennis Dlugos, Victor Biton, Gregory D Cascino, Mickael R Sperling, Kore Liow, Blanca Vazquez, Eric B Segal, Daniel Tarquinio, Weldon Mauney, Jay Desai, Adrian L Rabinowicz, Enrique Carrazana, null null
Final results from a Phase 3, long-term, open-label, repeat-dose safety study of diazepam nasal spray for seizure clusters in patients with epilepsy. Epilepsia 62 (10) (2021)
Ravnoor Singh Gill, Hyo-Min Lee, Benoit Caldairou, Seok-Jun Hong, Carmen Barba, Francesca Anzellotti, Ludovico D'Incerti, Vanessa Cristina Mendes Coelho, Matteo Lenge, Mira Semmelroch, Dewi Victoria Schrader, Fabrice Bartolomei, Maxime Guye, Andreas Schulze-Bonhage, Horst Urbach, Kyoo Ho Cho, Fernando Cendes, Renzo Guerrini, Graeme Jackson, Robert Edward Hogan, Neda Bernasconi, Andrea Bernasconi
Multicenter Validation of a Deep Learning Detection Algorithm for Focal Cortical Dysplasia. Neurology 97 (16) (2021)
Ian Miller, James W Wheless, Robert Edward Hogan, Dennis Dlugos, Victor Biton, Gregory D Cascino, Mickael R Sperling, Kore Liow, Blanca Vazquez, Eric B Segal, Daniel Tarquinio, Weldon Mauney, Jay Desai, Adrian L Rabinowicz, Enrique Carrazana, null null
Consistent safety and tolerability of Valtoco® (diazepam nasal spray) in relationship to usage frequency in patients with seizure clusters: Interim results from a phase 3, long-term, open-label, repeat-dose safety study. Epilepsia open 6 (3) (2021)
Robert Edward Hogan
Epilepsy as a Disease of White Matter. Epilepsy currents 21 (1) (2020)
Robert Edward Hogan, Zachary Grinspan, Erika Axeen, Belinda Marquis, B Keith Day
COVID-19 in Patients With Seizures and Epilepsy: Interpretation of Relevant Knowledge of Presenting Signs and Symptoms. Epilepsy currents 20 (5) (2020)
Robert Edward Hogan, Daniel Tarquinio, Mickael R Sperling, Pavel Klein, Ian Miller, Eric B Segal, Adrian L Rabinowicz, Enrique Carrazana
Pharmacokinetics and safety of VALTOCO (NRL-1; diazepam nasal spray) in patients with epilepsy during seizure (ictal/peri-ictal) and nonseizure (interictal) conditions: A phase 1, open-label study. Epilepsia 61 (5) (2020)
Robert Edward Hogan, Barry E Gidal, Barry Koplowitz, Luana P Koplowitz, Richard E Lowenthal, Enrique Carrazana
Bioavailability and safety of diazepam intranasal solution compared to oral and rectal diazepam in healthy volunteers. Epilepsia 61 (3) (2020)
Robert Edward Hogan
Delay of Treatment, After Diagnosis, as a Contributor to the "Treatment Gap" in Epilepsy. Epilepsy currents 19 (6) (2019)
Robert Edward Hogan
Predicting Response to Treatment of Epileptic Seizures: How Much Time and How Many AEDs Do We Need to Try? Epilepsy currents 19 (5) (2019)
Rachel Gurrell, Donal Gorman, Mark Whitlock, Adam Ogden, David S Reynolds, Bree DiVentura, Bassel Abou-Khalil, Michael Gelfand, John Pollard, Robert Edward Hogan, Gregory Krauss, Michael Sperling, Blanca Vazquez, Robert T Wechsler, Daniel Friedman, Richard P Butt, Jacqueline French
Photosensitive epilepsy: Robust clinical efficacy of a selective GABA potentiator. Neurology 92 (15) (2019)
Robert Edward Hogan
Mortality in Epilepsy: Referral to a Specialty Center Makes a Difference. Epilepsy currents 20 (1) (2019)